UBS AM
VBIV

UBS AM’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

UBS AM’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,820
Closed -$80.9K – 2768
2022
Q3 		$80.9K Sell
3,820
-1,350
-26% -$36.4K ﹤0.01% 2704
2022
Q2 		$125K Hold
5,170
– – ﹤0.01% 2625
2022
Q1 		$257K Hold
5,170
– – ﹤0.01% 2630
2021
Q4 		$363K Hold
5,170
– – ﹤0.01% 2642
2021
Q3 		$482K Hold
5,170
– – ﹤0.01% 2521
2021
Q2 		$520K Buy
5,170
+85
+2% +$8.29K ﹤0.01% 2523
2021
Q1 		$474K Sell
5,085
-7
-0.1% -$710 ﹤0.01% 2411
2020
Q4 		$420K Buy
+5,092
New +$434K ﹤0.01% 2346

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return